Genesee Capital Advisors’s CryoPort CYRX Stock Holding History

Genesee Capital Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,048	Closed	-$240K	–	117
2021 Q4	$240K	Hold	4,048	–	–	0.11%	94
2021 Q3	$269K	Buy	+4,048	New	+$250K	0.13%	91
2021 Q2	–	Sell	-41,440	Closed	-$2.15M	–	64
2021 Q1	$2.15M	Sell	41,440 -25,595	-38%	-$1.56M	1.28%	29
2020 Q4	$2.94M	Sell	67,035 -1,616	-2%	-$77K	1.93%	17
2020 Q3	$3.25M	Sell	68,651 -4,225	-6%	-$171K	2.68%	9
2020 Q2	$2.2M	Sell	72,876 -20,890	-22%	-$465K	2.05%	10
2020 Q1	$1.6M	Buy	+93,766	New	+$1.64M	1.53%	19

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Genesee Capital Advisors's CYRX Position: Q1 2022 in Review

Genesee Capital Advisors sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 4,048 shares — an estimated $240K sold.

Genesee Capital Advisors first reported a position in CYRX in Q1 2020 and held it in 7 quarters. The position peaked at $3.25M in Q3 2020. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

Genesee Capital Advisors reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
Genesee Capital Advisors sold 4,048 CryoPort shares in Q1 2022, an estimated $240K.
Genesee Capital Advisors first reported a position in CryoPort in Q1 2020 and held it in 7 quarters.
Genesee Capital Advisors's CryoPort position peaked at $3.25M in Q3 2020.
200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Genesee Capital Advisors's 13F filing for Q1 2022, filed 25 May 2022.